ABCF2P2

Across TCGA pan-cancer cohorts, ABCF2P2 RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated ABCF2P2 data layer.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher ABCF2P2 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated ABCF2P2 expression acts as an unfavorable survival marker, although some lineages such as STAD and ESCA show a favorable association.

OV, KICH, and SKCM are the cancer types where ABCF2P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	OS	Tertile	IV	0.236	0.649	.007	78	view →
KICH	DFS	Tertile	All	0.043	0.971	<.001	63	view →
SKCM	DFS	Tertile	II,III,IV	0.266	0.723	<.001	42	view →
PAAD	DFS	Tertile	All	0.227	0.484	.002	27	view →
UCEC	DFS	Tertile	III,IV	0.671	0.807	.022	24	view →
ACC	DFS	Tertile	All	0.388	0.619	.023	21	view →
MESO	OS	Tertile	IV	0.077	0.592	.019	18	view →
COAD	OS	Tertile	All	0.113	0.806	<.001	18	view →
GBM	DFS	Tertile	All	0.075	0.250	<.001	18	view →
LUAD	DFS	Tertile	II,III,IV	0.178	0.721	.008	18	view →
BLCA	OS	Tertile	IV	0.166	0.586	.030	9	view →
STAD	OS	Tertile	IV	0.682	0.258	.040	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

ABCF2P2–OV (OS)

Open the OV breakdown →